Bright Minds Biosciences Inc (DRUG) Stock Price, Quote & News

Company Profile

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develo...

Industry: Biotechnology

Sector: Healthcare

Phone: 647 865 8622

Website: brightmindsbio.com

Address:

19 Vestry Street, New York, United States

Lowkeyoptions Apr. 4 at 1:33 AM

$OMER pharma company doing clinical trials and never had a reverse split $RGC $DRUG $GME Ceo is a boss

0 · Reply

Digitalization2026 Apr. 3 at 4:44 PM

$SRXH $AIXI $DRUG $HKD $GME

0 · Reply

Lowkeyoptions Apr. 2 at 7:53 PM

$OMER most promising bio I've seen $DRUG MOVE SHOULD BE IMCOMING IMO. THEY'RE SHIPPING ALREADY. Always do your own research and stand on it

0 · Reply

Digitalization2026 Apr. 2 at 7:22 PM

$SRXH 👀 $BYND $GME $DRUG $HKD

0 · Reply

topstockalerts Apr. 2 at 7:09 PM

$DRUG look who’s waking up now

0 · Reply

Digitalization2026 Apr. 2 at 6:30 PM

$ANNA $DRUG $QQQ $SPY $SRXH 👇 🤫

0 · Reply

Lowkeyoptions Apr. 2 at 5:07 PM

$OMER $RGC $MRNA $DRUG HUGE NEWS ADVANTAGE FOR AMERICAN PHARMA Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs https://www-cnbc-com.cdn.ampproject.org/v/s/www.cnbc.com/amp/2026/04/02/trump-pharmaceutical-tariffs-100percent.html?amp_js_v=0.1&amp_gsa=1#webview=1&cap=swipe

0 · Reply

cashonthebarrelhead Apr. 2 at 4:48 PM

$LEXX added 5K and $1.01. To the small time profit takers, you are selling way to early. Go do some dd on $DRUG and see what $NVO paid for Emisphere… $1.8BN which would put Lexaria at $75 a share for a comparative value. Just be patient, we are very close to like changing money imo. T

0 · Reply

Digitalization2026 Apr. 2 at 4:37 PM

🚀 $SRXH — LIVE ACTION 👀 We’re in regular trading and holding $0.13–$0.14 💡 That’s strength — no flush, no panic, just steady positioning 📊 WHAT’S HAPPENING: • Still relatively easy to short • BUT borrow costs slowly rising 📈 👉 Pressure is building quietly 📌 THIS RANGE MATTERS: • $0.12 = confirmed base • $0.14 = testing strength • Break $0.16 = momentum unlock ⚡ 🌍 BACKDROP: • Crypto volatility rising • Treasury shifts + macro uncertainty • Capital rotating into new narratives 🚨 KEY POINT: No major news yet… and price STILL holding 👉 When news drops (any day, any time)… sub-$0.15 may be gone for good 💥 SETUP: • Not crowded • Thin zones above • Volume = trigger 🔥 TARGETS: $0.20 → $0.50 → $1+ Momentum: $3–5+ Stretch: $10+ 💎 👉 This is how moves start — quietly NFA 💎🚀 $ANNA $SPY $QQQ $DRUG https://www.emjx.ai

0 · Reply

Makingmillions192 Apr. 1 at 7:39 PM

$CYCN $DRUG $LEXX 🚀

0 · Reply

Bright Minds Biosciences Inc at TD Cowen Healthcare Conference Transcript

Wed, 25 Feb 2026 16:30:00 -0500 - 5 weeks ago

Bright Minds Biosciences to Present at Upcoming Conferences

2026-02-17T11:31:20.000Z - 6 weeks ago

BTIG Maintains Buy Rating for Bright Minds Biosciences (DRUG) with $147 Target | DRUG Stock News

Fri, 09 Jan 2026 11:56:00 -0500 - 3 months ago

Bright Minds Biosciences Announces Closing of US$175 Million Public Offering

2026-01-08T07:57:10.000Z - 3 months ago

Bright Minds Biosciences (DRUG) Prices $175M Public Offering

Wed, 07 Jan 2026 21:33:00 -0500 - 3 months ago

Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock

Wed, 07 Jan 2026 15:00:21 -0500 - 3 months ago

Bright Minds Biosciences: Positive BREAKTHROUGH Study Data Warrants 'Strong Buy' Rating

2026-01-07T13:05:22.000Z - 3 months ago

Bright Minds Biosciences, Praxis Precision Medicines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Tue, 06 Jan 2026 16:00:00 -0500 - 3 months ago

Bright Minds Biosciences Announces Launch of US$100 Million Public Offering

2026-01-06T18:31:59.000Z - 3 months ago

BTIG Raises Price Target for Bright Minds Biosciences (DRUG) to $147 | DRUG Stock News

2026-01-06T18:00:09.000Z - 3 months ago

Bright Minds Biosciences Inc BMB-101 Topline data announcement Transcript

Tue, 06 Jan 2026 11:52:33 -0500 - 3 months ago

New Bright Minds Epilepsy Drug Cuts Seizures, Lifts Stock On Tuesday

2026-01-06T15:07:53.000Z - 3 months ago

Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday

2026-01-06T13:00:04.000Z - 3 months ago

Bright Minds Biosciences (DRUG) Surges on Successful Trial Results

Tue, 06 Jan 2026 07:16:00 -0500 - 3 months ago

Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE)

2026-01-06T09:04:44.000Z - 3 months ago

Bright Minds To Unveil Topline Results For BMB-101 Phase 2 Trial In Absence Seizures And DEE

Mon, 05 Jan 2026 16:30:00 -0500 - 3 months ago

Bright Minds to Announce Topline Results for BMB-101 Phase 2 Trial in Absence Seizures and Developmental and Epileptic Encephalopathies on Tuesday, January 6, 2026

2026-01-02T13:30:17.000Z - 3 months ago

Bright Minds Biosciences (DRUG) Maintains Buy Rating with $80 Price Target | DRUG Stock News

2025-12-30T16:00:54.000Z - 3 months ago

Bright Minds Biosciences (DRUG) Sees Stable Analyst Rating Today | DRUG Stock News

Tue, 25 Nov 2025 16:30:00 -0500 - 4 months ago

Bright Minds Biosciences to Present at Piper Sandler 37th Annual Healthcare Conference and 2025 AES Annual Meeting

2025-11-25T14:55:03.000Z - 4 months ago

Wall Street Analysts Think Bright Minds Biosciences Inc. (DRUG) Could Surge 36.27%: Read This Before Placing a Bet

2025-11-17T22:29:36.000Z - 4 months ago

Why Bright Minds Biosciences Stock Topped the Market on Monday

Mon, 17 Nov 2025 06:50:00 -0500 - 4 months ago

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)

2025-11-15T01:53:30.000Z - 5 months ago

Sio Capital Management, LLC Reduces Stake in Bright Minds Biosciences Inc

Thu, 06 Nov 2025 06:30:00 -0500 - 5 months ago

Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH

2025-10-15T12:50:03.000Z - 6 months ago

Bright Minds Biosciences Inc. (DRUG) is on the Move, Here's Why the Trend Could be Sustainable

2025-09-18T13:55:01.000Z - 7 months ago

Wall Street Analysts Believe Bright Minds Biosciences Inc. (DRUG) Could Rally 81.29%: Here's is How to Trade

2025-09-15T12:33:59.000Z - 7 months ago

Bright Minds Biosciences (DRUG) Maintains 'Buy' Rating with $85 Price Target | DRUG Stock News

2025-09-08T17:54:11.000Z - 7 months ago

Large Patient Population Is Key Driver For Bright Minds' Growth

2025-09-05T10:56:42.000Z - 7 months ago

Bright Minds Biosciences (DRUG) Launches $100 Million ATM Offering

2025-09-05T00:00:00.000Z - 7 months ago

BRIGHT MINDS BIOSCIENCES ANNOUNCES AT-THE-MARKET OFFERING

Tue, 20 May 2025 08:00:00 -0400 - 11 months ago

Bright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D Day on May 20, 2025

Wed, 07 May 2025 16:45:18 -0400 - 11 months ago

Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside

2025-05-07T20:45:18.000Z - 11 months ago

Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside

Mon, 28 Apr 2025 08:00:00 -0400 - 1 year ago

Bright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 Study

Wed, 16 Apr 2025 12:09:11 -0400 - 1 year ago

Bright Minds Biosciences: A Buy With A Major Catalyst In Q2 2025

2025-02-15T04:14:47.000Z - 1 year ago

COMMODORE CAPITAL LP's Strategic Acquisition in Bright Minds Biosciences Inc

2025-02-10T20:16:59.000Z - 1 year ago

Sio Capital Management, LLC Acquires Significant Stake in Bright Minds Biosciences Inc

2025-02-07T18:23:53.000Z - 1 year ago

JANUS HENDERSON GROUP PLC Acquires Shares in Bright Minds Biosciences Inc

Sun, 26 Jan 2025 06:32:26 -0500 - 1 year ago

Bright Minds Biosciences: Looking To Change Scope Of Epilepsy Disorder Treatments With BMB-101

Tue, 07 Jan 2025 06:50:00 -0500 - 1 year ago

Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer

Wed, 13 Nov 2024 12:59:00 -0500 - 1 year ago

Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a Month

Mon, 04 Nov 2024 14:41:00 -0500 - 1 year ago

Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement

2024-11-04T16:05:09.000Z - 1 year ago

EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?

Wed, 30 Oct 2024 01:07:00 -0400 - 1 year ago

Bright Minds Biosciences: BMB-101's Phase 2 Trials Could Unlock Epilepsy Market Potential

Mon, 28 Oct 2024 08:21:00 -0400 - 1 year ago

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update

2024-10-23T01:06:51.000Z - 1 year ago

Cormorant Asset Management's Strategic Acquisition of Bright Minds Biosciences Shares

Oct 21, 2024, 8:30 AM EDT - 1 year ago

Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data

Oct 18, 2024, 6:50 AM EDT - 1 year ago

Bright Minds Biosciences Announces US$35 Million Non-Brokered Private Placement

Oct 16, 2024, 10:45 AM EDT - 1 year ago

Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C/2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models

Oct 16, 2024, 5:57 AM EDT - 1 year ago

Biotech stock tumbles after unexplained 1,446% gain

Oct 15, 2024, 9:09 PM EDT - 1 year ago

Bright Minds is Unaware of Any Material Changes

Oct 3, 2024, 9:00 AM EDT - 1 year ago

Bright Minds Biosciences announces participation in upcoming scientific conferences and partnering events

Sep 19, 2024, 10:00 AM EDT - 1 year ago

Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th

Sep 12, 2024, 8:00 AM EDT - 1 year ago

Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy

Aug 8, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Biosciences Announces Positive qEEG (Quantitative Electroencephalogram) Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Jul 20, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Jul 12, 2023, 10:33 AM EDT - 2 years ago

CSE Bulletin: Consolidation - Bright Minds Biosciences Inc. (DRUG)

Jul 11, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Announces Effective Date of Share Consolidation

Jun 22, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Announces Proposed Share Consolidation

Apr 19, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Receives a Favorable Written Opinion from the International Searching Authority for BMB-202

Apr 10, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research

Feb 27, 2023, 6:50 AM EST - 3 years ago

Bright Minds Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023

Feb 17, 2023, 6:50 AM EST - 3 years ago

Bright Minds Biosciences Announces Non-Executive Director Appointment

Feb 8, 2023, 4:05 PM EST - 3 years ago

Bright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent Director and Audit Committee Requirements

Jan 27, 2023, 4:05 PM EST - 3 years ago

Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Jan 9, 2023, 4:05 PM EST - 3 years ago

Bright Minds Biosciences Announces Resignation of Board Member

Dec 2, 2022, 7:07 PM EST - 3 years ago

Bright Minds Biosciences Announces Closing of Non-Brokered Private Placement

Nov 28, 2022, 6:50 AM EST - 3 years ago

Bright Minds Biosciences Announces Non-Brokered Private Placement

Nov 23, 2022, 11:35 AM EST - 3 years ago

Bright Minds Biosciences Appoints Drug Development Executive Mark A. Smith M.D.

Sep 7, 2022, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of Directors

Aug 31, 2022, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of BMB-101 for Dravet Syndrome

Aug 30, 2022, 3:35 PM EDT - 3 years ago

Bright Minds Biosciences Announces Closing of $4 Million Unit Offering

Aug 23, 2022, 9:07 PM EDT - 3 years ago

Bright Minds Announces Pricing of Overnight Marketed Offering of Units

Aug 22, 2022, 7:05 PM EDT - 3 years ago

Bright Minds Announces Overnight Marketed Offering of Units

Aug 18, 2022, 3:34 PM EDT - 3 years ago

Bright Minds Biosciences Comments on Recent Trading Activity

Jun 27, 2022, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization

Lowkeyoptions Apr. 4 at 1:33 AM

$OMER pharma company doing clinical trials and never had a reverse split $RGC $DRUG $GME Ceo is a boss

0 · Reply

Digitalization2026 Apr. 3 at 4:44 PM

$SRXH $AIXI $DRUG $HKD $GME

0 · Reply

Lowkeyoptions Apr. 2 at 7:53 PM

$OMER most promising bio I've seen $DRUG MOVE SHOULD BE IMCOMING IMO. THEY'RE SHIPPING ALREADY. Always do your own research and stand on it

0 · Reply

Digitalization2026 Apr. 2 at 7:22 PM

$SRXH 👀 $BYND $GME $DRUG $HKD

0 · Reply

topstockalerts Apr. 2 at 7:09 PM

$DRUG look who’s waking up now

0 · Reply

Digitalization2026 Apr. 2 at 6:30 PM

$ANNA $DRUG $QQQ $SPY $SRXH 👇 🤫

0 · Reply

Lowkeyoptions Apr. 2 at 5:07 PM

0 · Reply

cashonthebarrelhead Apr. 2 at 4:48 PM

0 · Reply

Digitalization2026 Apr. 2 at 4:37 PM

0 · Reply

Makingmillions192 Apr. 1 at 7:39 PM

$CYCN $DRUG $LEXX 🚀

0 · Reply

cashonthebarrelhead Apr. 1 at 7:32 PM

$LEXX This isnt even real volume...and if penny flippers just waited to the real volume comes we would be around $1 now and thats nothing...GO LOOK at the $DRUG run a few years a go. This can replicate it...the tech and disease states are that strong. Look what $CYCN did today on only mere 1.5% of a company lol almost 400%.

0 · Reply

cashonthebarrelhead Apr. 1 at 1:24 PM

$LEXX just put profits from $CYCN in here. LEXX can do a $DRUG type move in the the most lucrative disease states in the world. The tech is proven, needed and will be front in center for many top drugs as a safer delivery with less side effects.

0 · Reply

erevnon Mar. 30 at 10:56 AM

BTIG reiterates Bright Minds Biosciences $DRUG at Buy and maintains the price target at https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

MurseOMoney Mar. 27 at 7:27 AM

$NUMIF not to be blindly optimistic, but this crash might the best thing to happen to us small buyers. Nothing has changed to their goals. They’re still partnered with Stella in providing service through clinics, they still have CCR for research, they still plan to be the backbone to educating future psychedelic practitioners. Now it’s just dirt cheap to buy before moving over to CSE, which is less stringent than TSX and has way more fintech and started biotech freedoms. (P.S. $DRUG is also on CSE and is doing just fine 👍🤞🙏)

0 · Reply

SharkCapital Mar. 26 at 11:58 PM

$BURU looking good, ready for the boooom- gonna be the next $DRUG

2 · Reply

cashonthebarrelhead Mar. 26 at 4:32 PM

$LEXX $LEXX a $DRUG type run is coming hear anthing under a few dollars will very cheap we will learn in a few says or week.

0 · Reply

CoffeeRocks Mar. 26 at 4:08 PM

$AIFF $DRUG 500% Runner $VCX $DXYZ Defense contracts

0 · Reply

Trick2MoneyisHavingSum Mar. 25 at 8:31 PM

$UGRO set your sell limit at $2,000+ $DRUG $RGC

0 · Reply

TilTUP Mar. 25 at 6:55 PM

$QNCX want to it flying like $TIL and $DRUG

0 · Reply

Stock__Hunter Mar. 24 at 1:21 PM

$UGRO tip.. trade/watch tickers that make sense.. $DRUG $SBET $HOLO $NITO etc... not AQZW

0 · Reply

OfficialStocktwitsUser Mar. 20 at 8:07 PM

$DRUG RSI: 28.19, MACD: -2.8499 Vol: 6.21, MA20: 78.55, MA50: 81.08 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

TheRealShortSqueezy Mar. 20 at 4:57 PM

Patience Wins Don’t give up. Not when it’s uncomfortable. Not when progress is slow. Not when no one is watching. Rest if you need to. Small caps market might now be looking hot but there are setups everyday that you could benefit from. Today, I closed $AZTR and it paid off from a $0.275 entry to fully out at $0.35! Market will turn around after this dip and there will be new themes in small caps. $WOLF $DFDV $NXTT $DRUG

0 · Reply

Market Cap	695.46M
Revenue (ttm)	0.00
Net Income (ttm)	-8.74M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	188,400
Avg Vol	129,690
Day's Range	N/A - N/A
Shares Out	9.73M
Stochastic %K	49%
Beta	-5.34
Analysts	Strong Sell
Price Target	$137.60